Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mir

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|April 27, 1988
MDL 72832: a potent and stereoselective ligand at central and peripheral 5-HT1A receptorsA K Mir, M Hibert, M D Tricklebank, et al.
The European Journal of Neuroscience|June 1, 2011
Neutralization of interleukin-1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in miceFredrik Clausen, Anders Hånell, Charlotte Israelsson, et al.
BJU International|March 2, 2002
The relationship of circulating insulin-like growth factor 1, its binding protein-3, prostate-specific antigen and C-reactive protein with disease stage in prostate cancerZ Latif, D C McMillan, A M Wallace, et al.
British Journal of Pharmacology|February 1, 1990
Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepamP C Moser, M D Tricklebank, D N Middlemiss, et al.
La Tunisie Medicale|April 27, 2010
[Hypereosinophilia syndrome complicated by mitral stenosis]S Ketari Jamoussi, B Ben Dhaou, M Nadia, et al.
European Journal of Pharmacology|October 14, 1986
Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidaseM G Palfreyman, A K Mir, M Kubina, et al.
Biochemical Pharmacology|August 1, 1989
Lactamimides: a novel chemical class of calcium antagonists with diltiazem-like propertiesM G Palfreyman, M W Dudley, H C Cheng, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 7, 2003
Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive ratsChristoph Wiessner, Florence M Bareyre, Peter R Allegrini, et al.
Journal of Neurochemistry|April 16, 2003
Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptorV Pignot, A E Hein, C Barske, et al.
Journal of Neurosurgery|October 17, 2007
Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expressionNiklas Marklund, Florence M Bareyre, Nicolas C Royo, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|April 27, 1988
MDL 72832: a potent and stereoselective ligand at central and peripheral 5-HT1A receptorsA K Mir, M Hibert, M D Tricklebank, et al.
The European Journal of Neuroscience|June 1, 2011
Neutralization of interleukin-1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in miceFredrik Clausen, Anders Hånell, Charlotte Israelsson, et al.
BJU International|March 2, 2002
The relationship of circulating insulin-like growth factor 1, its binding protein-3, prostate-specific antigen and C-reactive protein with disease stage in prostate cancerZ Latif, D C McMillan, A M Wallace, et al.
British Journal of Pharmacology|February 1, 1990
Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepamP C Moser, M D Tricklebank, D N Middlemiss, et al.
La Tunisie Medicale|April 27, 2010
[Hypereosinophilia syndrome complicated by mitral stenosis]S Ketari Jamoussi, B Ben Dhaou, M Nadia, et al.
European Journal of Pharmacology|October 14, 1986
Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidaseM G Palfreyman, A K Mir, M Kubina, et al.
Biochemical Pharmacology|August 1, 1989
Lactamimides: a novel chemical class of calcium antagonists with diltiazem-like propertiesM G Palfreyman, M W Dudley, H C Cheng, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 7, 2003
Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive ratsChristoph Wiessner, Florence M Bareyre, Peter R Allegrini, et al.
Journal of Neurochemistry|April 16, 2003
Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptorV Pignot, A E Hein, C Barske, et al.
Journal of Neurosurgery|October 17, 2007
Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expressionNiklas Marklund, Florence M Bareyre, Nicolas C Royo, et al.
Pageof 6